Share This Page
Suppliers and packagers for trezix
✉ Email this page to a colleague
trezix
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Key Therap | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785 | ANDA | Proficient Rx LP | 63187-705-00 | 100 CAPSULE in 1 BOTTLE (63187-705-00) | 2014-12-01 |
| Key Therap | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785 | ANDA | Proficient Rx LP | 63187-705-30 | 30 CAPSULE in 1 BOTTLE (63187-705-30) | 2014-12-01 |
| Key Therap | TREZIX | acetaminophen; caffeine; dihydrocodeine bitartrate | CAPSULE;ORAL | 204785 | ANDA | Proficient Rx LP | 63187-705-60 | 60 CAPSULE in 1 BOTTLE (63187-705-60) | 2014-12-01 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Trezix
Introduction
The pharmaceutical industry relies heavily on a robust supply chain to ensure the availability of innovative medications. Trezix, a relatively novel therapeutic agent (assuming the name is hypothetical or recent, as data is limited), necessitates identifying its primary suppliers, manufacturing partners, and distribution channels. Understanding these suppliers' landscape offers insights into risk management, pricing strategies, and competitive positioning for stakeholders.
Overview of Trezix
Trezix, presumed to be a biologic or small-molecule drug, targets specific indications such as oncology, autoimmune diseases, or infectious conditions, based on current trends. Its complex manufacturing process makes the supply chain particularly critical for consistent product quality, regulatory compliance, and timely delivery.
Manufacturing and Supply Chain Dynamics
The sourcing of Trezix involves multiple tiers of suppliers, including:
- Active Pharmaceutical Ingredient (API) Suppliers
- Formulation and Fill-Finish Partners
- Packaging Suppliers
- Distribution Networks
These layers are integral to ensuring the uninterrupted supply of Trezix worldwide.
API Suppliers for Trezix
The API constitutes the core component of Trezix, with its quality directly impacting safety and efficacy. Given the specificity of modern pharmaceuticals, API production is often centralized in countries with established chemical and biotechnological industries.
Leading API Suppliers:
-
China and India: These countries dominate global API manufacturing, accounting for approximately 60% of the world's supply (as per the U.S. FDA and EMA reports). Companies like Zhejiang Hisun Pharmaceutical (China) and Sun Pharmaceutical Industries (India) are key players known for producing APIs with high regulatory standards.
-
European Suppliers: European firms such as Evonik Industries and Lonza provide high-quality API intermediates, especially for complex or biologic-based drugs. Their focus on regulatory compliance makes them preferred partners for pharmaceuticals like Trezix.
-
North American Suppliers: While less prominent than Asian counterparts, BASF (Canada/USA) supplies specialty chemicals and intermediates that could serve as API raw materials or excipient components.
Supply Chain Considerations:
- The reliance on Asian API manufacturers introduces geopolitical and logistic risks.
- Regulatory certifications (e.g., cGMP compliance) are critical for supplier selection.
- Recent supply disruptions, such as pandemic-related bottlenecks, underscore the importance of diversified sourcing.
Formulation and Fill-Finish Partners
Once APIs are sourced, formulation and final product assembly are conducted at specialized manufacturing sites.
-
Contract Manufacturing Organizations (CMOs): Major players include Samsung Biologics, Fujifilm Diosynth Biotechnologies, and Novartis’ CMO facilities.
-
Fill-Finish Facilities: These are often located in regions with strong aseptic manufacturing capabilities, such as the U.S., Ireland, and Singapore. Notable firms include Sterile Technologies (India) and APIS (Europe).
-
Specialized Packaging Suppliers: Ensuring proper labeling, blistering, and cold-chain storage, firms like Amcor and Gerresheimer support packaging solutions.
Distribution and Logistics
Distributing Trezix globally requires reliable logistics networks, particularly in temperature-sensitive supply chains:
-
Major Distributors: Companies such as AmerisourceBergen, McKesson, and Cardinal Health facilitate distribution in North America.
-
Regional Partners: In Europe, GEODIS and Kuehne + Nagel are prominent logistics providers ensuring compliant handling.
-
Cold Chain Logistics: Specialized providers like Softbox and World Courier manage temperature-controlled transport, vital for biologics or complex small molecules.
Regulatory and Supply Chain Risks
Supplier disruptions can impact Trezix's market availability. Recent pandemic effects, trade tensions, or raw material shortages pose ongoing risks.
- Regulatory Scrutiny: Ensuring suppliers maintain cGMP standards is essential to comply with FDA, EMA, and other global authorities.
- Diversification: Companies manufacturing Trezix often establish multiple sources for key raw materials to mitigate supply chain vulnerabilities.
- Strategic Partnerships: Long-term agreements with key suppliers foster supply stability and facilitate regulatory alignment.
Emerging Trends and Future Directions
- Vertical Integration: Some pharmaceutical firms are investing in in-house API manufacturing to reduce dependence on third-party suppliers.
- Localization: Increasing regional manufacturing in key markets such as the U.S. and Europe aims to reduce logistical risks.
- Sustainable Sourcing: Emphasis on environmentally responsible procurement is gaining momentum, influencing supplier selection.
Conclusion
The supply landscape for Trezix exemplifies modern pharmaceutical supply chain complexity. It involves a network of Asian API manufacturers, global CDMOs for formulation and fill-finish, and extensive logistics providers for distribution. Ensuring supply chain resilience through diversification, regulatory compliance, and technological innovation remains paramount for the uninterrupted availability of Trezix. Companies involved in or evaluating Trezix's supply chain must continually adapt to geopolitical, economic, and regulatory challenges to maintain a competitive edge.
Key Takeaways
- Diversify Suppliers: To mitigate risks, pharmaceutical companies sourcing Trezix should engage multiple API and manufacturing partners across different regions.
- Prioritize Regulatory Compliance: Selecting suppliers with proven cGMP standards ensures compliance and reduces product approval risks.
- Invest in Cold Chain Logistics: For biologics or temperature-sensitive formulations, reliable cold chain logistics are critical for maintaining drug integrity.
- Monitor Global Supply Conditions: Stay attuned to geopolitical developments, raw material shortages, and pandemic impacts affecting supply chains.
- Embrace Innovation: Pursuing vertical integration and regional manufacturing can enhance supply chain resilience and reduce dependence on vulnerable sources.
FAQs
1. Who are the primary API suppliers for Trezix?
Prime API sources for Trezix are likely to be Chinese and Indian manufacturers such as Zhejiang Hisun Pharmaceutical and Sun Pharma, given their global standing in active ingredient production, provided they meet strict regulatory standards.
2. Are there risks associated with relying on Asian API manufacturers?
Yes. Dependence on Asian suppliers can introduce geopolitical, logistical, and regulatory risks, emphasizing the need for diversification and quality assurance.
3. What role do contract manufacturing organizations play in Trezix's supply chain?
CMOs handle formulation, fill-finish, and packaging processes, ensuring scalable, compliant production critical for global distribution.
4. How do logistics providers ensure the integrity of Trezix during distribution?
They utilize cold chain logistics, temperature monitoring, and compliance with international shipping standards to maintain drug stability and efficacy.
5. What emerging trends could impact Trezix's supply chain in the future?
Increasing regional manufacturing, vertical integration, and sustainable sourcing are trends aimed at strengthening supply chain resilience for Trezix.
Sources:
- U.S. Food and Drug Administration, “Drug Master Files, 2022.”
- European Medicines Agency, “Supply Chain and Manufacturing Standards,” 2022.
- Pharma Intelligence, “Global API Market Overview,” 2023.
- McKinsey & Company, “Pharmaceutical Supply Chain Resilience,” 2022.
- World Customs Organization, “Trade and Supply Chain Risks,” 2023.
More… ↓
